search
Back to results

A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries (TFCC)

Primary Purpose

Wrist Injuries, PRP

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Platelet-rich plasma (PRP)
Sponsored by
William Beaumont Army Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wrist Injuries focused on measuring TFCC, PRP

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  1. Adult patients consenting for wrist injection, who additionally consent to participate in this study.
  2. MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL)

Exclusion criteria:

  1. Patients who do not choose to participate in the study or who do not wish to have an injection
  2. Patients who want an injection - but do not want to be randomized.
  3. Patients who do not complete one of the follow up documentations.
  4. Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol.

Sites / Locations

  • Lola NortonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental - PRP injection

control - Saline injection

Arm Description

2cc of PRP is injected into the ulnocarpal joint

2cc of 0.9% sterile saline is injected into the ulnocarpal joint

Outcomes

Primary Outcome Measures

Disability of the Army Shoulder Hand (DASH)
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Disability of the Army Shoulder Hand (DASH)
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Disability of the Army Shoulder Hand (DASH)
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Disability of the Army Shoulder Hand (DASH)
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Disability of the Army Shoulder Hand (DASH)
SCALE: 0-100 (0 being a good result and 100 being complete disability)

Secondary Outcome Measures

Michigan Hand Outcome Questionnaire (MHOQ
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)
Mayo Wrist Score (Mayo)
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)
Pain Anxiety Symptom Scale (PASS)
SCALE: 0-100 (100 meaning a patient has a high level of anxiety, pain, apprehension; while a lower scale indicates a patient has no concerns or anxiety about pain. The average is about 38 and the standard deviation is 20)
Single Assessment Numerical Evaluation (SANE)
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)

Full Information

First Posted
February 1, 2019
Last Updated
October 19, 2020
Sponsor
William Beaumont Army Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03830775
Brief Title
A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries
Acronym
TFCC
Official Title
A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 2, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
William Beaumont Army Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Platelet-rich Plasma (PRP) is formed when a patient's blood sample is concentrated by a commercially available centrifuge. The sample then contains a high concentration of growth factors and has been used for numerous indications in a number of joints. This process has not yet been proven for non-operative management of the Triangular FibroCartilage Complex (TFCC), which is a very commonly injured soft tissue structure in the wrist. This study seeks to determine the efficacy of PRP for TFCC injuries.
Detailed Description
Platelet-rich Plasma (PRP) therapy has recently been indicated in the treatment of joint pain, arthritis, tendonitis, and to augment surgical treatment has become increasingly common (Hsu) PRP is obtained from obtaining an autologous blood sample, which is then condensed in a small commercial centrifuge to isolate a concentrated sample of platelets and growth factors. This sample contains high concentrations of Platelet-derived growth factors (PDGF), transforming growth factors β (TGFβ), insulin-like growth factor-1 (IGF1), and vascular endothelial growth factor-1 (VEGF) all of which aid in healing of soft tissues. (Padilla) The blood sample is autologous, the concentration is prepared in the clinic, and the complications of the injection are no greater than any other injection given in the clinic. (Hsu) In addition to being safe, PRP is efficacious. PRP has been well-studied including 10 prospective randomized controlled trials proving the effectiveness of PRP for knee osteoarthritis alone. (Dai) Strong evidence has also been reported in support of PRP use for bone healing (Bibbo, Tsai) tendinopathy (Mishra, Peerbooms) cartilage healing (Mei-Dan), and for augmentation of both ligament reconstruction (Fallouh) and repair (Mazzocca). Furthermore, the use of PRP has been shown to be a more cost effective treatment as compared to traditional methods in both chronic wound management and tendonitis (Gosens, Dougherty) PRP has not been studied in the wrist. Ulnar-sided wrist pain, most commonly involving the Triangular fibrocartilage complex (TFCC) is both difficult to diagnosis and treat,(Kleinmann, Fulcher, Graham) The TFCC is a meniscal homologue which acts to stabilize the wrist and to dissipate compressive forces. Tears within this soft tissue structure are painful and heal slowly. (Palmer, Palmer). Immobilization, steroid injections, or surgical treatment are the mainstays of treatment. However, PRP has not been studied as a treatment modality. The purpose of this analysis is to study the efficacy of PRP injection in the treatment of a TFCC tear. The null hypothesis is that there is no difference between injection into the wrist of PRP and saline (placebo). The investigators hypothesize that PRP will reduce pain as compared to placebo.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wrist Injuries, PRP
Keywords
TFCC, PRP

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
42 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental - PRP injection
Arm Type
Experimental
Arm Description
2cc of PRP is injected into the ulnocarpal joint
Arm Title
control - Saline injection
Arm Type
Placebo Comparator
Arm Description
2cc of 0.9% sterile saline is injected into the ulnocarpal joint
Intervention Type
Procedure
Intervention Name(s)
Platelet-rich plasma (PRP)
Intervention Description
PRP is obtained from obtaining an autologous blood sample, which is then condensed in a small commercial centrifuge to isolate a concentrated sample of platelets and growth factors. This sample contains high concentrations of Platelet-derived growth factors (PDGF), transforming growth factors β (TGFβ), insulin-like growth factor-1 (IGF1), and vascular endothelial growth factor-1 (VEGF) all of which aid in healing of soft tissues. (Padilla) The blood sample is autologous, the concentration is prepared in the clinic, and the complications of the injection are no greater than any other injection given in the clinic. All patients will have a blood sample prepared for PRP. The patient will then be blinded and half will randomly be assigned to PRP injection (2cc) and half will be randomly assigned to placebo (2cc of 0.9% sterile saline)
Primary Outcome Measure Information:
Title
Disability of the Army Shoulder Hand (DASH)
Description
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Time Frame
Pre-injection
Title
Disability of the Army Shoulder Hand (DASH)
Description
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Time Frame
2 weeks post injection
Title
Disability of the Army Shoulder Hand (DASH)
Description
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Time Frame
3 months post injection
Title
Disability of the Army Shoulder Hand (DASH)
Description
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Time Frame
6 months post injection
Title
Disability of the Army Shoulder Hand (DASH)
Description
SCALE: 0-100 (0 being a good result and 100 being complete disability)
Time Frame
12 months post injection
Secondary Outcome Measure Information:
Title
Michigan Hand Outcome Questionnaire (MHOQ
Description
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)
Time Frame
Pre-injection, 2 weeks, 3 months
Title
Mayo Wrist Score (Mayo)
Description
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)
Time Frame
Pre-injection, 2 weeks, 3 months, 6 months, 12 months
Title
Pain Anxiety Symptom Scale (PASS)
Description
SCALE: 0-100 (100 meaning a patient has a high level of anxiety, pain, apprehension; while a lower scale indicates a patient has no concerns or anxiety about pain. The average is about 38 and the standard deviation is 20)
Time Frame
Pre-injection, 2 weeks, 3 months
Title
Single Assessment Numerical Evaluation (SANE)
Description
SCALE: 0-100 (with 100 being a great result and 0 being considerable pain and dysfunction)
Time Frame
Pre-injection, 2 weeks, 3 months, 6 months, 12 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: Adult patients consenting for wrist injection, who additionally consent to participate in this study. MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL) Exclusion criteria: Patients who do not choose to participate in the study or who do not wish to have an injection Patients who want an injection - but do not want to be randomized. Patients who do not complete one of the follow up documentations. Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Polmear
Phone
(303) 910-8665
Email
michael.polmear@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John C Dunn
Organizational Affiliation
WBAMC Staff Hand Surgeon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lola Norton
City
El Paso
State/Province
Texas
ZIP/Postal Code
79903
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Larissa Schmersal
Phone
915-742-9502
Email
larissa.a.schmersal.civ@mail.mil

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25063744
Citation
Padilla S, Orive G, Sanchez M, Anitua E, Hsu WK. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2014 Aug;22(8):469-70. doi: 10.5435/JAAOS-22-08-469. No abstract available.
Results Reference
result
PubMed Identifier
24292930
Citation
Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, Canale ST, Kelly FB. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013 Dec;21(12):739-48. doi: 10.5435/JAAOS-21-12-739.
Results Reference
result
PubMed Identifier
28012636
Citation
Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017 Mar;33(3):659-670.e1. doi: 10.1016/j.arthro.2016.09.024. Epub 2016 Dec 22.
Results Reference
result
PubMed Identifier
21422467
Citation
Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011 Jun;39(6):1200-8. doi: 10.1177/0363546510397173. Epub 2011 Mar 21.
Results Reference
result
PubMed Identifier
20448192
Citation
Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010 Feb;38(2):255-62. doi: 10.1177/0363546509355445.
Results Reference
result
PubMed Identifier
7229292
Citation
Palmer AK, Werner FW. The triangular fibrocartilage complex of the wrist--anatomy and function. J Hand Surg Am. 1981 Mar;6(2):153-62. doi: 10.1016/s0363-5023(81)80170-0.
Results Reference
result
PubMed Identifier
18261664
Citation
Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am. 2008 Jan;33(1):40-8. doi: 10.1016/j.jhsa.2007.10.009.
Results Reference
result

Learn more about this trial

A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries

We'll reach out to this number within 24 hrs